Apellis Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Offer Letter, dated as of November 16, 2018, by and between the Registrant and Adam Townsend (Filed With SEC on February 28, 2022)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 28, 2022)
- Offer Letter, dated as of April 20, 2020, by and between the Registrant and Nur Nicholson (Filed With SEC on February 28, 2022)
- Open Market Sale AgreementSM, dated as of January 20, 2022, by and between Apellis Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on January 20, 2022)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 25, 2021)
- Form of Capped Call Transaction Confirmation (Filed With SEC on May 7, 2020)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 27, 2020)
- Form of Capped Call Transaction Confirmation (Filed With SEC on September 16, 2019)
- Offer Letter, dated as of April 13, 2018, by and between the Registrant and Lukas Scheibler (Filed With SEC on May 7, 2019)
- Offer Letter, dated as of October 9, 2017, by and between the Registrant and Timothy Sullivan (Filed With SEC on October 20, 2017)
- Offer Letter, dated as of March 7, 2017, by and between the Registrant and Steven Axon (Filed With SEC on October 13, 2017)
- VOTINGAGREEMENT (Filed With SEC on October 13, 2015)
